Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Metadata
Title
Correction to: Comparison of 8-year knee osteoarthritis progression in 2 siblings: a case-based review
Authors
Margaret L. Gourlay
Linda L. Gourlay
Publication date
01-10-2020
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 10/2020
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05278-y

Other articles of this Issue 10/2020

Clinical Rheumatology 10/2020 Go to the issue

Clinical Image

Osteonecrosis of the lunate in systemic sclerosis—an underappreciated vascular complication?

Perspectives in Rheumatology

Certain perspectives about the use of corticosteroids for managing hospitalized patients with rheumatic diseases

Original Article

Effectiveness of ustekinumab in patients with psoriatic arthritis in a real-world, multicenter study

Original Article

Is axial magnetic resonance imaging useful in early juvenile spondyloarthritis—preliminary report

Letter to the Editor

Biosimilars for vasculitis: promise requires validation by quality studies

Original Article

TGF-β1 +869C/T polymorphism increases susceptibility to rheumatoid arthritis in North Indian population

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits